Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel S Leibman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2015
Engineering T Cells to Functionally Cure HIV-1 InfectionRachel S Leibman, James L Riley
Mbio|July 26, 2012
Enterococcus faecalis produces abundant extracellular structures containing DNA in the absence of cell lysis during early biofilm formationAaron M T Barnes, Katie S Ballering, Rachel S Leibman, et al.
Nature Communications|July 30, 2016
Antimicrobial peptides trigger a division block in Escherichia coli through stimulation of a signalling systemSrujana S Yadavalli, Jeffrey N Carey, Rachel S Leibman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2020
HIV-Resistant and HIV-Specific CAR-Modified CD4<sup>+</sup> T Cells Mitigate HIV Disease Progression and Confer CD4<sup>+</sup> T Cell Help In VivoColby R Maldini, Kevin Gayout, Rachel S Leibman, et al.
Expert Review of Anticancer Therapy|July 1, 2024
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLCPierre Peterlin, Esma Saada-Bouzid, Mor Moskovitz, et al.
Plos Pathogens|October 13, 2017
Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptorRachel S Leibman, Max W Richardson, Christoph T Ellebrecht, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2015
Engineering T Cells to Functionally Cure HIV-1 InfectionRachel S Leibman, James L Riley
Mbio|July 26, 2012
Enterococcus faecalis produces abundant extracellular structures containing DNA in the absence of cell lysis during early biofilm formationAaron M T Barnes, Katie S Ballering, Rachel S Leibman, et al.
Nature Communications|July 30, 2016
Antimicrobial peptides trigger a division block in Escherichia coli through stimulation of a signalling systemSrujana S Yadavalli, Jeffrey N Carey, Rachel S Leibman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2020
HIV-Resistant and HIV-Specific CAR-Modified CD4<sup>+</sup> T Cells Mitigate HIV Disease Progression and Confer CD4<sup>+</sup> T Cell Help In VivoColby R Maldini, Kevin Gayout, Rachel S Leibman, et al.
Expert Review of Anticancer Therapy|July 1, 2024
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLCPierre Peterlin, Esma Saada-Bouzid, Mor Moskovitz, et al.
Plos Pathogens|October 13, 2017
Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptorRachel S Leibman, Max W Richardson, Christoph T Ellebrecht, et al.
Pageof 1